Detection of gene amplification in MYCN, C-MYC, MYCL1, ERBB2, EGFR, AKT2, and human papilloma virus in samples from cervical smear normal cytology, intraepithelial cervical neoplasia (CIN I, II, III), and cervical cancer
Article Sidebar
Main Article Content
Objectives: To perform detection of MYCN, C-MYC, MYCL1, ERBB2, EGFR, and AKT2 amplification. Additionally, to detect human papillomavirus in samples from normal cytology smear, cervical intraepithelial neoplasia (CIN) I, II, and III and cervical cancer patients.
Methods: Papillomavirus (HPV) genotyping by reverse line blot (RLB) performed and gene amplification by detection with real-time PCR with Taqman probes.
Results: HPV was present in 4% of the patients with normal cytology, 48% in CIN I, 63.6% in CIN II, 64% in CIN III, and 70.8% in cervical cancer. Genes amplified in cervical cancer were MYCN (39.1%), ERBB2 (34.7%), and MYCL1 (30.4%); showed higher amplification in high-grade lesions and cervical cancer in relation to low-grade lesions and normal cytology with statistically significant differences. Besides the genes, C-MYC, EGFR, and AKT2 were amplified in samples from patients with cervical cancer by 12%, 18%, and 13%, respectively; we did not find statistical differences.
Conclusion: Higher prevalence of gene amplification and HPV was found in high-grade cervical lesions and cervical cancer.
- HPV
- Amplification
- MYCN
- C-MYC
- MYCL1
- ERBB2
- EGFR
- AKT2
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.Estimates of worldwide burden of cancer in 2008: GLOBOCAN2008. Int J Cancer. 2010; 127: 2893-917.2.Muñoz N, Bosch FX, Sanjose S, Herrero R, Castellsague X,Shah V, et al. Epidemiologic classification of humanpapillomavirus types associated with cervical cancer. N EnglJ Med. 2003, 348: 518-27.3.Savelyeva L, Schwab M. Amplification of oncogenes revisited:from expression profiling to clinical application. CancerLetters. 2001; 167: 115-23.4.Brison O. Gene amplification and tumor progression. BiochimBiophys Acta. 1993; 1155: 25-41.5.Malakh SG, Korshunov A, Stroganov AM, Poltaraus AB. Fastdetection of MYCN copy number Alterations in brain neuronaltumors by real-time PCR. J Clin Lab Anal. 2008; 22: 123-30.6.Mark HF, Feldman D, Das S, Sun CL, Samy M, Lathrop J.HER-2/neu oncogene amplification in cervical cancer Studiedby fluorescent in situ hybridization. Genet Test. 1999; 3: 237-42.7.Kinoshita M, Ikei N, Shin S, Inui S, Hirao T, Aono T.Relationship between human papillomavirus and oncogenes(C-MYC, N-MYC) amplification in human cervical Cancers.Nippon Gan Chiryo Gakkai Shi. 1990; 25: 2828-35.8.van den Brule A, Schouls L. GP5 +/6 +PCR reverse line blotfollowed by enables rapid analysis and high-throughputidentification of human papillomavirus genotype. J ClinMicrobiol. 2002, 40: 779-87.9.Jacobs MV, Walboomers JM, Snijders PJ, Voorhorst FJ,Verheijen RH, Fransen-Daalmeijer N, et al. Distribution of 37HPV types mucosotropic in women with cytologically normalcervical smears: the age-related patterns for high-risk and low-risk types. Int J Cancer. 2000; 87: 221-7.10. Schiffman MH, Bauer HM, Hoover RN, Glass AG, CadellDM, Rush BB, et al. Epidemiologic evidence showing thathuman papillomavirus infection causes most cervicalintraepithelial neoplasia. J Natl Cancer Inst. 1993; 85: 958-64.11. Cobo F, Concha A, Ortiz M. Human papillomavirus (HPV)type distribution in females with abnormal cervical cytology.a correlation with histological study. Open Virol J. 2009; 3:60-6.12. Cancer Gene Census. Amplified Cancer Genes. Trust SangerInstitute. [February 2010]. Cambridge: URL: http://www.sanger.ac.uk/genetics/CGP/Census/amplification.shtml13. Mitra AB, Murty VVVS, Pratap M, Sodhani P, Chaganti SK.ERBB2 (HER2/neu) oncogene is frequently amplified insquamous cell carcinoma of the uterine cervix. Cancer Res1994; 54: 637-9.14. Baker VV, Hatch KD, Shingleton HM. Amplification of thec-myc proto-oncogene in cervical carcinoma. J Surg Oncol.1988; 39: 225-8.15. Golijow CD, Abba MC, Mouron SA, Gómez MA, Dulout FN.C-MYC gene amplification detected in preinvasiveintraepithelial cervical lesions Int J Gynecol Cancer. 2001;11: 462-5.16. Mao X, Orchard G, Lillington DM, Russell-Jones R, YoungBD, Whittaker SJ. Amplification and overexpression of JUNBis associated with primary cutaneous T-cell lymphoma. Blood.2003; 101: 1513-9.17. Sharma A, Pratap M, Sawhney VM, Khan IU, Bhambhani S,Mitra AB. Frequent amplification of C-erbB2 (HER-2/neu)oncogene in cervical carcinoma as detected by non-fluorescencein situ hybridization technique on paraffin sections. Oncology.1999; 56: 83-7.18. Zhang A, Maner S, Betz R, Angstrom T, Stendahl U, BergmanF, et al. Genetic alterations in cervical carcinomas: Frequentlow-level amplifications of oncogenes are associated withhuman papillomavirus infection. Int J Cancer. 2002; 101:427-33.19. Kersemaekers AM, Fleuren GJ, Kenter GG, Van den BroekLJ, Uljee SM , Hermans J , et al. Oncogene alterations incarcinomas of the uterine cervix: overexpression of theepidermal growth factor receptor is associated with poorprognosis. Clin Cancer Res. 1999; 5: 577-86.20. García JM, García D, Muñoz C, Herrero A, Rodrigo JP,Suárez C, et al. Frequent genetic and biochemical alterationsof the PI 3-K/AKT/PTEN pathway in head and neck squamouscell carcinoma. Int J Cancer. 2004; 114: 242-8.
Downloads
- Consuelo Romero-Sanchez, Alberto Gomez-Gutierrez, Piedad Elena Gomez, María Consuelo Casas-Gomez, Ignacio Briceño, C677t (rs1801133 ) MTFHR gene polymorphism frequency in a colombian population , Colombia Medica: Vol. 46 No. 2 (2015)
- Korina María Rojas, Martha Roa, Ignacio Briceño, Carolina Guaneme, Alberto Gómez, Polimorfismos de 17 marcadores STR del cromosoma-Y en una muestra poblacional del altiplano cundiboyacense* , Colombia Medica: Vol. 42 No. 1 (2011)
- Mónica Díaz, Victoria Villegas, Clara López De Mesa, Diana Torres, Jaime Bernal, Alberto Gómez, Ignacio Briceño, Aplication of authenticity criteria in mitochondrial studies on archaic bone remains from a prehispanic Muisca population , Colombia Medica: Vol. 41 No. 4 (2010)
- Marta Bermúdez, Ignacio Briceño, Fabián Gil, Jaime Bernal, Homocisteína y polimorfismos de cistationina b sintasa y metilentetrahidrofolato reductasa en población sana de Colombia. , Colombia Medica: Vol. 37 No. 1 (2006)
- Dabeiba Adriana García, Yazmín Rocío Arias, Fabio Ancízar Aristizábal, Detection of genes mutations in the K-ras, H-ras and EGFR in samples of blood plasma and cervical smears for patients with cervical intraepithelial neoplasia III and cervical cancer , Colombia Medica: Vol. 40 No. 1 (2009)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The copy rights of the articles published in Colombia Médica belong to the Universidad del Valle. The contents of the articles that appear in the Journal are exclusively the responsibility of the authors and do not necessarily reflect the opinions of the Editorial Committee of the Journal. It is allowed to reproduce the material published in Colombia Médica without prior authorization for non-commercial use